MedAvail Holdings, Inc. (MDVLQ)

USD 0.0

(0.0%)

EBITDA Summary of MedAvail Holdings, Inc.

  • MedAvail Holdings, Inc.'s latest annual EBITDA in 2022 was -41.76 Million USD , down -2.35% from previous year.
  • MedAvail Holdings, Inc.'s latest quarterly EBITDA in 2023 Q2 was -4.02 Million USD , up 2.5% from previous quarter.
  • MedAvail Holdings, Inc. reported an annual EBITDA of -40.64 Million USD in 2021, down -111.95% from previous year.
  • MedAvail Holdings, Inc. reported an annual EBITDA of -23.76 Million USD in 2020, down -1.23% from previous year.
  • MedAvail Holdings, Inc. reported a quarterly EBITDA of -4.02 Million USD for 2023 Q2, up 2.5% from previous quarter.
  • MedAvail Holdings, Inc. reported a quarterly EBITDA of -10.74 Million USD for 2022 Q2, up 11.71% from previous quarter.

Annual EBITDA Chart of MedAvail Holdings, Inc. (2022 - 2016)

Historical Annual EBITDA of MedAvail Holdings, Inc. (2022 - 2016)

Year EBITDA EBITDA Growth
2022 -41.76 Million USD -2.35%
2021 -40.64 Million USD -111.95%
2020 -23.76 Million USD -1.23%
2019 -19.15 Million USD -387.82%
2018 -3.89 Million USD -3.97%
2017 -3.75 Million USD 6.23%
2016 -3.99 Million USD 0.0%

Peer EBITDA Comparison of MedAvail Holdings, Inc.

Name EBITDA EBITDA Difference
Babylon Holdings Limited -176.72 Million USD 76.368%
ETAO International Co., Ltd. -893.88 Million USD 95.328%
Micron Solutions, Inc. -308.4 Thousand USD -13442.433%
Motus GI Holdings, Inc. -11.23 Million USD -271.906%
ThermoGenesis Holdings, Inc. -7.74 Million USD -439.599%
Titan Medical Inc. 7.51 Million USD 655.429%
UpHealth, Inc. -16.89 Million USD -147.189%